Position in ICLR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$65,141
-$5,161,233 QoQ
Shares Held
375
-97.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#330
of 422 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $124,186,888 across 28 Diagnostics & Research names. ICLR ranks #17 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
477,841 | $63,471,620 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
131,127 | $25,336,358 | |
| 3 | NTRA |
Natera, Inc.
|
48,046 | $13,042,086 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
17,602 | $9,266,396 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
10,200 | $5,401,818 | |
| 6 | VCYT |
Veracyte, Inc.
|
69,585 | $4,086,727 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
1,631 | $817,718 | |
| 8 | GH |
Guardant Health, Inc.
|
3,578 | $536,807 |
All Filings in ICLR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,141 | 375 | Shares | Sole | 2026-08-13 | |
| 2024-03-31 | $5,226,374 | 15,557 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $2,581,315 | 9,119 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,757,303 | 19,319 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $318,504 | 1,273 | Shares | Sole | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||